Related Experiment Video
Updated: May 28, 2026
09:20
Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
Potential anticancer activity of young Carpinus betulus leaves
Ewa Cieckiewicz1, Luc Angenot, Thierry Gras
1University of Liège, CIRM, Laboratory of Pharmacognosy, Liège, Belgium.
Summary
Researchers discovered pheophorbide a in young Carpinus betulus leaves, demonstrating its anticancer properties and photoactivable potential. This chlorophyll derivative was found in high quantities, challenging previous findings.
Area of Science:
- Phytochemistry
- Pharmacology
- Natural Products
Background:
- Continuing research for novel anticancer compounds from the Walloon Region forest.
- Phytochemical investigation of EtOAc extract from Carpinus betulus leaves.
Purpose of the Study:
- To isolate and identify compounds with anticancer properties from Carpinus betulus leaves.
- To evaluate the anticancer and photoactivable properties of isolated compounds.
Main Methods:
- Bioguided isolation of pheophorbide a.
- Identification using nuclear magnetic resonance and mass spectrophotometry.
- Anticancer activity evaluation using MTT assay and phase-contrast microscopy in human cancer cell lines.
Main Results:
- Pheophorbide a was isolated and identified from Carpinus betulus young leaves.
- Pheophorbide a exhibited significant growth inhibitory activities against various human cancer cell lines.
- The compound demonstrated photoactivable properties.
- High quantities of pheophorbide a were quantified in young leaves, contrary to existing literature.
Conclusions:
- Pheophorbide a is a key anticancer compound found in young Carpinus betulus leaves.
- The study highlights the potential of pheophorbide a as a photoactivable anticancer agent.
- This research challenges the established understanding of pheophorbide a distribution in plants.
Related Concept Videos
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...